arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

OptimizeRx Corp

OPRX
$8.63 ▼ -1.16 (-11.85%) at close
Industrials ·Services-Business Services, NEC ·USServices-Business Services, NEC
65 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
64
Health
Fair
Neutral
auto_awesome

Analytical Summary

OptimizeRx Corp shows mixed fundamentals. Consider comparing against peers in the Industrials sector before making investment decisions.

Market Cap $162.1M
Dividend Yield —
Revenue Growth -29.8% ↘
Op. Margin -0.4% ↘
ROIC -0.0% ↘
FCF / Share $0.46 ↗
Trailing P/E —
Price / Book 1.2x
FCF Yield 5.3%
Debt / Equity 0.15
info Valuation on last close. End-of-day price, Nov 5, 2026.

65-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$20.50M
↓ -29.8% —
Net Income Profit after all expenses
$-495.00K
↑ +77.5% —
Operating Margin Operating profit as % of sales
-0.4%
↓ -121.5% 58th
FCF / Share Free cash flow per share
$0.46
↑ +1855.1% —
Long-Term Debt Long-term obligations
$19.69M
↓ -16.6% —

Health Breakdown

Profitability ↑
61
Returns ↑
51
Financial Health ↓
68
Cash Quality ↑
93

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 16 years · 65 quarters